MLH1 and endometrial carcinoma: Guida et al. showed that especially the combination of hMLH1 promoter methylation and P16 promoter methylation is more frequently seen in endometrial hyperplasia and endometrial carcinoma compared to normal endometrium [14, 15, 34].